Search This Blog

Tuesday, July 23, 2019

Karyopharm upped to Overweight from Neutral by JPMorgan

Target to $16 from $8
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)